Stay updated on Anti-MAP Therapy in Crohn's: Clinical Trial
Sign up to get notified when there's something new on the Anti-MAP Therapy in Crohn's: Clinical Trial page.

Latest updates to the Anti-MAP Therapy in Crohn's: Clinical Trial page
- Check3 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA banner announces the NIH website transition and says “Super Intelligence” will replace “Artificial Intelligence” across NIH content. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check45 days agoChange Detected403 Forbidden page is now shown, replacing the study record content. Related sections such as sponsor, investigators, and location information have been removed from the page.SummaryDifference18%

- Check52 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the page, reflecting a new version of the study record. This update is metadata and does not change the study content, eligibility criteria, outcomes, or locations.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.6.6 updated on the page, signaling a new version of the document or assets. This is a backend/version control update rather than a substantive change to the study content.SummaryDifference0.0%

Stay in the know with updates to Anti-MAP Therapy in Crohn's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-MAP Therapy in Crohn's: Clinical Trial page.